Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.

Monika F, Shao H, Jain AG, Tackett M, Kuykendall AT, Sallman DA, Yan M

DOI: 10.1093/ajcp/aqag115
Published: 2026 Oct 10
Container: American journal of clinical pathology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ajcp/aqag115,
  title = {Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.},
  author = {Monika F and Shao H and Jain AG and Tackett M and Kuykendall AT and Sallman DA and Yan M},
  year = {2026},
  journal = {American journal of clinical pathology},
  doi = {10.1093/ajcp/aqag115},
  url = {https://doi.org/10.1093/ajcp/aqag115}
}

RIS

TY  - JOUR
TI  - Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.
AU  - Monika F
AU  - Shao H
AU  - Jain AG
AU  - Tackett M
AU  - Kuykendall AT
AU  - Sallman DA
AU  - Yan M
PY  - 2026
JO  - American journal of clinical pathology
DO  - 10.1093/ajcp/aqag115
UR  - https://doi.org/10.1093/ajcp/aqag115
ER  -

APA

F, M., H, S., AG, J., M, T., AT, K., DA, S., & M, Y. (2026). Subclonal AGGF1::PDGFRB rearrangement in a myelodysplastic/myeloproliferative neoplasm with suboptimal response to imatinib.. American journal of clinical pathology. https://doi.org/10.1093/ajcp/aqag115

Source records

pubmed · retrieved 2026-11-10T11:45:01.954Z
europe-pmc · retrieved 2026-11-10T11:45:01.969Z